Roche's Genentech, GSK, J&J and Amgen are among the biopharmas creating Amazon Alexa skills. (Credit: Shutterstock)
May 31, 2022 10:55 AM EDTUpdated 04:51 PM
Pharma
Marketing

Speak­ing of the fu­ture: Ama­zon Alexa and the voice-en­abled app mar­ket for phar­ma and health­care

Beth Snyder Bulik

Senior Editor

Wor­ried about that cough or won­der­ing what dif­fer­ent med­ica­tions can be tak­en at the same time? Just ask Alexa. That’s what more and more peo­ple …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times